Screener
Immunome IMNM Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Immunome in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The source filing: Immunome’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219425
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Accounts payable | $5,534 | $3,339 |
| Accrued expenses and other current liabilities | 21,878 | 41,651 |
| Total current liabilities | 27,412 | 44,990 |
| Operating lease liabilities, net of current portion | 3,694 | 3,855 |
| Total liabilities | 31,106 | 48,845 |
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued or outstanding at March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $0.0001 par value; 300,000,000 shares authorized at March 31, 2026 and December 31, 2025; 113,171,396 and 113,133,199 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 11 | 11 |
Item 1. Financial Statements.
FAQ
- What is Immunome's operating lease liabilities?
- Immunome (IMNM) reported operating lease liabilities of $3.69M in Q1 2026.
- How has Immunome's operating lease liabilities changed year-over-year?
- Immunome's operating lease liabilities decreased by 22.6% year-over-year, from $4.77M to $3.69M.
- What is the long-term trend for Immunome's operating lease liabilities?
- Over 2 years (2023 to 2025), Immunome's operating lease liabilities has grown at a 69.6% compound annual growth rate (CAGR), from $1.34M to $3.86M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.
Ask your AI about Immunome's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude